During the past decade, Onkologische Schwerpunktpraxis Celle conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Schwerpunktpraxis Celle" #1 collaborator was "Crolll Gmbh" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Schwerpunktpraxis Celle" are "Lymphoma" (2 trials) and "Chronic Myelogenous Leukemia (CML)" (1 trials). Many other conditions were trialed in "Onkologische Schwerpunktpraxis Celle" in a lesser frequency.

Most popular intervention types in "Onkologische Schwerpunktpraxis Celle" are "Biological" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials), "radiation therapy" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Schwerpunktpraxis Celle" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Onkologische Schwerpunktpraxis Celle". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Onkologische Schwerpunktpraxis Celle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Schwerpunktpraxis Celle, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".